AccelNest
United States
- Delaware
- 10/11/2022
- Pre Series A
- $2,500,000
AccelNest is your trusted partner in your journey of being a successful entrepreneur. Our mission is to disrupt the startup ecosystem as an incubator, an accelerator and an investor.
- Industry Venture Capital and Private Equity Principals
- Website http://www.accelnest.com/
- LinkedIn https://www.linkedin.com/company/accelnest/
Related People
Kalyan GummadamInvestor
United States -
Fremont, California
Domain Expertise: Strategic Sourcing Practice Development, Global Strategic Sourcing, Negotiations, Indirect Sourcing, Negotiations Training, Contracts Management, Supplier Management & Segmentation, Category Playbooks, Strategic Sourcing Tools and Templates, Supply Chain Optimization, Low Cost Sourcing Modeling, AI/ML based Analytics Tools and Technologies, Cross-company Aggregate Partnerships
Strategy: Business Planning & Strategy, NPI Product Life Cycle Management, Road map and Pipeline building, Strategic Alliances and Partnerships, Fund raising, Start-up Advisory
Finance: Working capital enhancements, AOP Process, Budgeting, Financial Modeling and FP&A
Analytics: AI /ML based Spend Analysis, Cost Modeling, Savings Tracker and Models, Finance Models
Operations: Due Diligence, M&A Integration, Operations/Supply Chain Transformation, Business Process Transformation, Cross Portfolio Company Initiatives, Lean Six Sigma
Industry Expertise: Private Equity, Information Technology, Healthcare, Automotive, Manufacturing, Financial Services, Retail, Travel( Airlines, Hotel , Agencies), Real Estate
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)